Forschung

Direkt zum Inhalt | Direkt zur Navigation

Benutzerspezifische Werkzeuge

Sektionen
Hepatitis-B-Virus
Sie sind hier: Startseite / Forschung / Hepatitis-B-Virus

Hepatitis-B-Virus

Ausgewählte Publikationen des Instituts zum Thema Hepatitis-B-Virus - HBV (chronologisch sortiert)

 


Hermans LE, Svicher V, Pas SD, Salpini R, Alvarez M, Ben Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Kose S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stockl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Weis N, Yalcinkaya T, Lepej SZ, Perno C, Boucher CA, Wensing AM. (2016). Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE). J Infect Dis. 213(1): 39-48. www.ncbi.nlm.nih.gov/pubmed/26136470


Geipel A, Seiz PL, Niekamp H, Neumann-Fraune M, Zhang K, Kaiser R, Protzer U, Gerlich WH, Glebe D. (2015). Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine. Antivir Ther. www.ncbi.nlm.nih.gov/pubmed/25560463

Hermans LE, Svicher V, Pas SD, Salpini R, Alvarez M, Ben Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Kose S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stockl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Weis N, Yalcinkaya T, Zidovec Lepej S, Perno C, Boucher CA, Wensing AM. (2015). Combined Analysis of the Prevalence of drug Resistant HBV in antiviral therapy Experienced patients in Europe (CAPRE). J Infect Dis. www.ncbi.nlm.nih.gov/pubmed/26136470


Gerlich WH, Glebe D, Gurtler LG, Kaiser R. (2014). Therapy of hepatitis B virus infections - potential and limitations. Intervirology. 57(3-4): 131-133. www.ncbi.nlm.nih.gov/pubmed/25034479

Neumann-Fraune M, Beggel B, Kaiser R, Obermeier M. (2014). Hepatitis B virus drug resistance tools: one sequence, two predictions. Intervirology. 57(3-4): 232-236. www.ncbi.nlm.nih.gov/pubmed/25034493

Neumann-Fraune M, Beggel B, Pfister H, Kaiser R, Verheyen J. (2013). High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates. J Med Virol. www.ncbi.nlm.nih.gov/pubmed/23408582


Beggel B, Neumann-Fraune M, Doring M, Lawyer G, Kaiser R, Verheyen J, Lengauer T. (2012). Genotyping hepatitis B virus dual infections using population-based sequence data. J Gen Virol. 93(Pt 9): 1899-1907. www.ncbi.nlm.nih.gov/pubmed/22694900

Begger B, Neumann-Fraune M, Döring M, Lawyer G, Kaiser R, Verheyen J, Lengauer T. (2012). Geno2pheno[HBV] - A web service to genotype HBV dual infections based on direct saquencing data. Reviews in Antiviral Therapy & Infectious Diseases. 277.

Neumann-Fraune M, Hart M, Kaiser R, Grässer FA, Verheyen J. (2012). Influence of the expression of truncated HBsAg on apoptosis in an hepatoma cell line. Reviews in Antiviral Therapy & Infectious Diseases. 254.

Neumann-Fraune M, Lubke N, Beggel B, Glebe D, Kaiser R, Verheyen J. (2012). Complex mutational patterns in drug resistant HBV isolates. J Hepatol. 56(2): S211-S212.

Verheyen J, Neumann-Fraune M, Berg T, Kaiser R, Obermeier M. (2012). The detection of HBsAg mutants expressed in vitro using two different quantitative HBsAg assays. J Clin Virol. 54(3): 279-281. www.ncbi.nlm.nih.gov/pubmed/22595307


Reuter S, Oette M, Wilhelm FC, Beggel B, Kaiser R, Balduin M, Schweitzer F, Verheyen J, Adams O, Lengauer T, Fatkenheuer G, Pfister H, Haussinger D. (2011). Prevalence and characteristics of hepatitis B and C virus infections in treatment-naive HIV-infected patients. Med Microbiol Immunol. 200(1): 39-49. www.ncbi.nlm.nih.gov/pubmed/20853118

Reuter S, Oette M, Wilhelm FC, Beggel B, Kaiser R, Balduin M, Schweitzer F, Verheyen J, Adams O, Lengauer T, Fatkenheuer G, Pfister H, Haussinger D. (2010). Prevalence and characteristics of hepatitis B and C virus infections in treatment-naive HIV-infected patients. Med Microbiol Immunol. www.ncbi.nlm.nih.gov/pubmed/20853118

Rhee SY, Margeridon-Thermet S, Nguyen MH, Liu TF, Kagan RM, Beggel B, Verheyen J, Kaiser R, Shafer RW. (2010). Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery. Antiviral Res. 88(3): 269-275. www.ncbi.nlm.nih.gov/pubmed/20875460

Awerkiew S, Daumer M, Reiser M, Wend UC, Pfister H, Kaiser R, Willems WR, Gerlich WH. (2007). Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient. J Clin Virol. 38(1): 83-86. www.ncbi.nlm.nih.gov/pubmed/17134939